Skip to content

Comparative study of ropivacaine rapid injection in spinal anesthesia for cesarean section

The infusion speed of ropivacaine during subarachnoid anesthesia may affect the needed dosage for cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17012249
Enrollment
Unknown
Registered
2017-08-04
Start date
2017-08-07
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean delivery

Interventions

Low-speed:Subarachnoid ropivacaine infusion was administrated at a speed of 0.05ml/s
Medium-speed:Subarachnoid ropivacaine infusion was administrated at a speed of 0.1ml/s
Fast-speed:Subarachnoid ropivacaine infusion was administrated at a speed of 0.5ml/s

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Term parturient of 155-165cm height, ASA classifications of I to II, without severe disease accompanied during pregnancy, determined to receive cesarean section delivery, whom sufficiently informed, and consented to the agreement.

Exclusion criteria

Exclusion criteria: Be allergic to amide local anesthetics, has chronic neurological or psychiatric disorders, with psychotropic drugs addition, contradicted to subarachnoid blockade , cases of twin pregnancy, pregnancy accompanied with hypertension, placenta previa, etc., or experienced twice or more abdominal surgeries.

Design outcomes

Primary

MeasureTime frame
Surgical incision pain;ranking score for surgical condition;perioperative pain and postoperative recovery;

Secondary

MeasureTime frame
motor blockade efficiency;recovery time for motor blockade of lower limbs;

Countries

China

Contacts

Public ContactXiaochun Zheng

Department of Anesthesiology, Fujian Provincial Hospital

Zhengxiaochun7766@163.com+86 13705058351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026